Sunfox Technologies

Sunfox is an integrated R&D and Mfg lab for social impact, based in foothills of Himalayas in Dehradun. A 90+ people team who joined forces together to reduce global deaths and permanent heart damage due to heart attacks and cardiac diseases. We help underserved communities, rural and urban communities to detect heart attacks timely to reduce the damage/deaths due to heart attacks. The Problem and scale- • Leading Cause of Death: Cardiovascular diseases (CVDs) are responsible for 28% of all deaths in India and 18 Mn Deaths Globally. • Annual Impact: 2 million heart attacks per year, with one heart attack every 40 seconds in India. • Daily Toll: Over 5,500 heart attacks daily just in India. Every 30-minute delay in treating a heart attack increases the risk of death by 7-10%, making early detection and intervention critical for survival. Market- The global cardiac monitoring market is projected to reach $28 billion by 2027, positioning Spandan as a powerful, scalable solution in an industry with massive growth potential. Product- Spandan is world’s smallest and smartest tool to detect heart attacks on smartphone with 99.76% accuracy. Spandan makes heart diagnosis as easy as using a thermometer at home. Why Spandan- 1. Reduction in Risk of Recurrent Heart Attack by Up to 60%. 2. Decrease in Heart Pump Efficiency Loss by 35%. 3. Reduction in Heart Failure Risk by Up to 40%. 4. Reduction in Disability from Repeated Heart Attacks by 50%. 5. Reduction in Mortality from Delays in Treatment by Up to 30% Current Scale- • 120+ People Team, Inhouse ISO13485 certified Factory, fully functional at 5000 units/month capacity, Licensed by in regulatory bodies in India, South Africa, Ghana, Kenya, Tanzania, US-FDA Applied, CE Mark Applied. • Sold in 20+ Countries, 5000+ Pincodes in India, 30000+ Active Users in India, 8000+ Clinics and doctors in India. • 500+ Units Deployed to Indian Army, Approved for use by All Insurance Companies • Product Launched by AIIMS Director, Recommended by ICMR for uses in Govt Health Programs, Endorsed by top international cardiologists • Series A Stage, Raised 25Cr+ in past rounds